Eight year GvHD-relapse-free survival is increased with Anti-human T-Lymphocyte IgG ATG-Fresenius (ATG-F) compared to CSA/Mtx alone for GvHD prophylaxis in Matched Unrelated Donor transplantation: long-term results from the randomized ATG-F Trial
BONE MARROW TRANSPLANTATION（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined